847019-77-6

Basic information

• Product Name: 6,9,12-Octadecatrienoic acid, 2-[(1-oxodecyl)oxy]-1-[[(1-oxodecyl)oxy]methyl]ethyl ester, (6Z,9Z,12Z)-
• CAS NO: 847019-77-6
• Molecular Formula: C41H72O6
• Molecular Weight: 661.019
• Mol File: 847019-77-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6,9,12-Octadecatrienoic acid, 2-[(1-oxodecyl)oxy]-1-[[(1-oxodecyl)oxy]methyl]ethyl ester, (6Z,9Z,12Z)-(CAS DataBase Reference)
• NIST Chemistry Reference: 6,9,12-Octadecatrienoic acid, 2-[(1-oxodecyl)oxy]-1-[[(1-oxodecyl)oxy]methyl]ethyl ester, (6Z,9Z,12Z)-(847019-77-6)
• EPA Substance Registry System: 6,9,12-Octadecatrienoic acid, 2-[(1-oxodecyl)oxy]-1-[[(1-oxodecyl)oxy]methyl]ethyl ester, (6Z,9Z,12Z)-(847019-77-6)

Safety Data

• Hazardous Substances Data: 847019-77-6(Hazardous Substances Data)

Upstream product

• 17598-93-5 1, 3-dicaprin 
• 54562-14-0 z,z,z-octadeca-6,9,12-trienoyl chloride 

Downstream Products

• 157500-74-8 C₂₁H₃₆O₄ 
• 110-38-3 decanoic acid ethyl ester 
• 31450-14-3 cis-6,cis-9,cis-12-octadecatrienoic acid ethyl ester 

Relevant articles and documents

TREATMENT OF NEURODEGENERATIVE CONDITIONS

A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety being selected from the group consisting of γ-linolenic acid, dihomo-γ-linolenic acid and arachidonic acid characterised in that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. Preferably the method is that wherein the lipid is administered for a duration and at a dose sufficient to maintain or elevate TGF-β1 levels in the patient to therapeutic levels.